Kopp, Alexander opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Kopp, Alexander

Patent Number:
Title:
Trans-4-{2-[4-(2,3-Dichlorophenyl)-Piperazin-1-Yl]-Ethyl}-N,N-Dimethylcarbamoyl-Cyclohexylamine For Treating Negative Symptoms Of Schizophrenia
Opposition Date:
Sep 29, 2021
Patent Number:
Title:
Apixaban Formulations
Opposition Date:
Aug 7, 2020
Patent Number:
Title:
Use Of Ulipristal Acetate For Treating Uterine Fibroids
Opposition Date:
Jul 2, 2020
Patent Number:
Title:
Heat Sterilization Of Glucocorticoidsteriods
Opposition Date:
Nov 27, 2018
Patent Number:
Title:
Propylene Glycol-Containing Peptide Formulations Which Are Optimal For Production And For Use In Injection Devices
Opposition Date:
Aug 21, 2018
Patent Number:
Title:
Methods For Purifying Steviol Glycosides And Uses Of The Same
Opposition Date:
Aug 9, 2018
Patent Number:
Title:
Pharmaceutical Formulation Comprising Ezetimibe
Applicant:
Opposition Date:
Apr 19, 2018
Patent Number:
Title:
Process For Manufacturing A Pharmaceutical Preparation Containing Glatiramer Acetate
Opposition Date:
Dec 21, 2017
Patent Number:
Title:
Compositions, Suitable For Oral Administration, Comprising A Triazolo [4, 5-D]Pyrimidin Derivate
Applicant:
Opposition Date:
Dec 18, 2017
Patent Number:
Title:
Treatment Of Solid Tumours With Rapamycin Derivatives
Applicant:
Opposition Date:
Feb 22, 2016

Latest patents of Kopp, Alexander opposed by its competitors

Patent:
Grant Date:
Sep 8, 2021
Title:
Implant And Method For The Production Thereof
Oppositions:
1

Want to track Kopp, Alexander?

Feel free to send us a message here and we will get back to you